Relationship between Insulin-Like Growth Factor I Levels, Early Insulin Treatment, and Clinical Outcomes of Very Low Birth Weight Infants
详细信息    查看全文
文摘
| Figures/TablesFigures/Tables | ReferencesReferences

Objectives

Insulin regulates the secretion of insulin-like growth factor I (IGF-I) in the newborn, and low levels of IGF-I have been linked to neonatal morbidity. As part of the Neonatal Insulin Replacement Therapy in Europe Trial, we investigated the impact of early insulin treatment on IGF-I levels and their relationship with morbidity and growth.

Study design

Prospective cohort analyses of data collected as part of an international randomized controlled trial. Blood samples (days 1, 3, 7, and 28), were taken for IGF-I bioassay from 283 very low birth weight infants (<1500聽g).

Results

Early insulin treatment led to a late increase in IGF-I levels between day 7 and 28 (P聽=聽.028). In the first week of life IGF-I levels were lower in infants with early hyperglycemia; mean difference 鈭?.10聽渭g/L (95% CI 鈭?.19, 鈭?.02, P聽=聽.02). Lower levels of IGF-I at day 28 were independently associated with an increased risk of chronic lung disease, OR 3.23 (95% CI, 1.09-9.10), and greater IGF-I levels were independently associated with better weight gain, 0.10聽kg (95% CI, 0.03-0.33, P聽=聽.02).

Conclusions

Early intervention with insulin is related to increased IGF-I levels at 28聽days. Low IGF-I levels are associated with hyperglycemia, increased morbidity, and reduced growth. Increasing IGF-I levels may improve outcomes of very low birth weight infants.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700